Insulin Pens Market Expected to Grow from USD 39.6B in 2025 to USD 71B by 2035 at 6.0% CAGR The insulin pens market is witnessing significant growth due to the increasing prevalence of diabetes ...

Brand-name GLP-1s come in fixed FDA-approved doses and delivery methods, such as prefilled injection pens, vials, or tablets (like Rybelsus). This isn’t necessarily the case for compounded GLP-1s.

Robert Roscoe, BSc. Pharm, ACRP, CDE, CPT, Pharmacist and Certified Diabetes Educator goes through the steps of proper injection technique when administering insulin.

The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...

Other side effects include injection site reactions, itching, rash, lipodystrophy, weight gain, and swollen hands and feet. The rapid-acting insulin aspart biosimilar joins two prior long-acting ...

"By using connected insulin pens, it may be possible to identify different patient behaviors and then plan and conduct targeted interventions for people living with diabetes who have difficulty ...

New research offers an alternative to daily insulin shots for the 8 million people in the United States with type 2 diabetes. Eli Lilly’s once-weekly insulin injection is just as effective as ...

The FDA cleared the Omnipod 5, the 1st device to enable automated insulin injection for those with type 2 diabetes.

As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will leave them in the lurch.